Intellia Therapeutics (NASDAQ:NTLA – Get Free Report)‘s stock had its “neutral” rating restated by stock analysts at Wedbush in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $14.00 price target on the stock. Wedbush’s target price indicates a potential upside of 0.65% from the stock’s previous close. Several […]

Starbucks (NASDAQ:SBUX – Get Free Report)‘s stock had its “sell” rating restated by Redburn Atlantic in a research report issued to clients and investors on Wednesday,Benzinga reports. They currently have a $77.00 price target on the coffee company’s stock, down from their prior price target of $84.00. Redburn Atlantic’s price target would indicate a potential […]